Novel brain permeant mTORC1/2 inhibitors are as efficacious as rapamycin or everolimus in mouse models of acquired partial epilepsy and tuberous sclerosis complex
| Autor: | Theilmann, Wiebke, Gericke, Birthe, Schidlitzki, Alina, Muneeb Anjum, Syed Muhammad, Borsdorf, Saskia, Harries, Timon, Roberds, Steven L., Aguiar, Dean J., Brunner, Daniela, Leiser, Steven C., Song, Dekun, Fabbro, Doriano, Hillmann, Petra, Wymann, Matthias P., Löscher, Wolfgang |
|---|---|
| Zdroj: | In Neuropharmacology 1 December 2020 180 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|
Full Text from ScienceDirect